Author: Nancy Humphrey
Study to explore nasal bacteria of children born by C-section
Nov. 10, 2022—Vanderbilt is recruiting pregnant women scheduled to undergo a repeat cesarean section at VUMC for a study of potential interventions to change the bacteria living in the nose of children born by C-section.
Low vision initiative for children lands new funding
Oct. 27, 2022—Vanderbilt's Project PAVE has received funding from the Tennessee Department of Intellectual and Developmental Disabilities to continue the program that has provided low-vision evaluations for more than 2,150 school-age children in Tennessee since 1993.
Study to explore why some gliomas spread like cancerous tumors
Oct. 27, 2022—Vanderbilt's Michael Dewan, MD, MSCI, has received a grant from the Pediatric Brain Tumor Foundation to study why some low-grade gliomas, a type of non-cancerous brain or spine tumor, spread and behave like cancerous tumors.
New chairs named to lead VUMC advisory boards
Oct. 27, 2022—Liz Potocsnak and Larisa Featherstone have been named to positions on Vanderbilt University Medical Center’s advisory boards.
Vanderbilt study finds that the most common oxygen saturation targets for hospitalized patients appear equally safe and effective
Oct. 24, 2022—A Vanderbilt study looked at the oxygen saturation target that results in optimal outcomes — number of days alive and free of mechanical ventilation — in 2,500 critically ill adults receiving mechanical ventilation.
Kidney diseases research collaboration renewed
Oct. 6, 2022—Vanderbilt University Medical Center and Bayer have agreed to continue a strategic research alliance to evaluate new drug candidates for the treatment of kidney diseases.
Major commitment bolsters Vanderbilt’s retinal vision research efforts
Sep. 22, 2022—A $10 million gift from the International Retinal Research Foundation will establish a center dedicated to retinal vision research at the Vanderbilt Eye Institute and a directorship to support a physician-scientist leader in the Department of Ophthalmology and Visual Sciences.
Calkins lands national award for research on blinding eye diseases
Sep. 8, 2022—Vanderbilt's David Calkins, PhD, has been selected by the Research to Prevent Blindness and Association of University Professors of Ophthalmology to receive the 2023 David F. Weeks Award for Outstanding Vision Research.
Family’s gift supports efforts of three pediatric clinicians
Sep. 8, 2022—The family of the late William (Bill) Long, MD, made a gift to establish the Dr. William R. Long Fund to support directorships, resident education, fellowships and psychologists in the Department of Pediatrics at Vanderbilt University Medical Center.
Study shows success at disproving allergies to sulfa antibiotics
Aug. 4, 2022—A Vanderbilt study shows that physicians can successfully identify and disprove low-risk sulfa antibiotic allergies using an oral antibiotic challenge in consenting patients prior to solid organ transplant.
For young concussion patients, managing visual symptoms crucial
Jul. 19, 2022—A policy statement from Vanderbilt and other institutions says it’s essential that pediatricians and other clinicians know how to screen, identify and initiate clinical management of visual symptoms after this common childhood injury.
Convalescent plasma doesn’t help severely ill COVID patients: study
Jul. 7, 2022—A Vanderbilt clinical trial shows that convalescent plasma, widely given to severely ill patients hospitalized with COVID-19 during the pandemic, does not improve their ability to survive or recover